The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer

George M. Yousef, Andreas Scorilas, Terukazu Nakamura, Mohamed Abd Ellatif, Riccardo Ponzone, Nicoletta Biglia, Furio Maggiorotto, Riccardo Roagna, Piero Sismondi, Eleftherios P. Diamandis

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background. Many members of the human kallikrein gene family were found to be differentially expressed in various malignancies and some of them are useful diagnostic/prognostic markers. KLK9 is a newly discovered human kallikrein gene that is expressed in several tissues including thymus, spinal cord, testis, prostate, breast, and ovary. Like other kallikreins, the KLK9 gene was found to be regulated by steroid hormones, mainly estrogens and progestins, in cancer cell lines. Experimental design. We studied the expression of KLK9 by quantitative RT-PCR in 169 breast cancer patients of different stages, grades and histological types. We also compared the relation between KLK9 expression and other clinicopathological variables and patient survival. Results. KLK9 expression is significantly higher in patients with early stage cancers (p = 0.039) and in patients with small tumor size (

Original languageEnglish
Pages (from-to)149-158
Number of pages10
JournalBreast Cancer Research and Treatment
Volume78
Issue number2
DOIs
Publication statusPublished - Mar 2003

Fingerprint

Kallikreins
Breast Neoplasms
Genes
Gene Expression
Neoplasms
Progestins
Thymus Gland
Testis
Prostate
Ovary
Spinal Cord
Estrogens
Breast
Research Design
Steroids
Hormones
Cell Line
Polymerase Chain Reaction
Survival

Keywords

  • Breast cancer
  • Cancer genes
  • Cancer predictive markers
  • Kallikreins
  • KLK9
  • Prognostic markers
  • PSA
  • Serine proteases
  • Tumor markers

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yousef, G. M., Scorilas, A., Nakamura, T., Ellatif, M. A., Ponzone, R., Biglia, N., ... Diamandis, E. P. (2003). The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Research and Treatment, 78(2), 149-158. https://doi.org/10.1023/A:1022931403825

The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. / Yousef, George M.; Scorilas, Andreas; Nakamura, Terukazu; Ellatif, Mohamed Abd; Ponzone, Riccardo; Biglia, Nicoletta; Maggiorotto, Furio; Roagna, Riccardo; Sismondi, Piero; Diamandis, Eleftherios P.

In: Breast Cancer Research and Treatment, Vol. 78, No. 2, 03.2003, p. 149-158.

Research output: Contribution to journalArticle

Yousef, GM, Scorilas, A, Nakamura, T, Ellatif, MA, Ponzone, R, Biglia, N, Maggiorotto, F, Roagna, R, Sismondi, P & Diamandis, EP 2003, 'The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer', Breast Cancer Research and Treatment, vol. 78, no. 2, pp. 149-158. https://doi.org/10.1023/A:1022931403825
Yousef, George M. ; Scorilas, Andreas ; Nakamura, Terukazu ; Ellatif, Mohamed Abd ; Ponzone, Riccardo ; Biglia, Nicoletta ; Maggiorotto, Furio ; Roagna, Riccardo ; Sismondi, Piero ; Diamandis, Eleftherios P. / The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. In: Breast Cancer Research and Treatment. 2003 ; Vol. 78, No. 2. pp. 149-158.
@article{023758c88c0f40a5aa83ea2d9e41345e,
title = "The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer",
abstract = "Background. Many members of the human kallikrein gene family were found to be differentially expressed in various malignancies and some of them are useful diagnostic/prognostic markers. KLK9 is a newly discovered human kallikrein gene that is expressed in several tissues including thymus, spinal cord, testis, prostate, breast, and ovary. Like other kallikreins, the KLK9 gene was found to be regulated by steroid hormones, mainly estrogens and progestins, in cancer cell lines. Experimental design. We studied the expression of KLK9 by quantitative RT-PCR in 169 breast cancer patients of different stages, grades and histological types. We also compared the relation between KLK9 expression and other clinicopathological variables and patient survival. Results. KLK9 expression is significantly higher in patients with early stage cancers (p = 0.039) and in patients with small tumor size (",
keywords = "Breast cancer, Cancer genes, Cancer predictive markers, Kallikreins, KLK9, Prognostic markers, PSA, Serine proteases, Tumor markers",
author = "Yousef, {George M.} and Andreas Scorilas and Terukazu Nakamura and Ellatif, {Mohamed Abd} and Riccardo Ponzone and Nicoletta Biglia and Furio Maggiorotto and Riccardo Roagna and Piero Sismondi and Diamandis, {Eleftherios P.}",
year = "2003",
month = "3",
doi = "10.1023/A:1022931403825",
language = "English",
volume = "78",
pages = "149--158",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer

AU - Yousef, George M.

AU - Scorilas, Andreas

AU - Nakamura, Terukazu

AU - Ellatif, Mohamed Abd

AU - Ponzone, Riccardo

AU - Biglia, Nicoletta

AU - Maggiorotto, Furio

AU - Roagna, Riccardo

AU - Sismondi, Piero

AU - Diamandis, Eleftherios P.

PY - 2003/3

Y1 - 2003/3

N2 - Background. Many members of the human kallikrein gene family were found to be differentially expressed in various malignancies and some of them are useful diagnostic/prognostic markers. KLK9 is a newly discovered human kallikrein gene that is expressed in several tissues including thymus, spinal cord, testis, prostate, breast, and ovary. Like other kallikreins, the KLK9 gene was found to be regulated by steroid hormones, mainly estrogens and progestins, in cancer cell lines. Experimental design. We studied the expression of KLK9 by quantitative RT-PCR in 169 breast cancer patients of different stages, grades and histological types. We also compared the relation between KLK9 expression and other clinicopathological variables and patient survival. Results. KLK9 expression is significantly higher in patients with early stage cancers (p = 0.039) and in patients with small tumor size (

AB - Background. Many members of the human kallikrein gene family were found to be differentially expressed in various malignancies and some of them are useful diagnostic/prognostic markers. KLK9 is a newly discovered human kallikrein gene that is expressed in several tissues including thymus, spinal cord, testis, prostate, breast, and ovary. Like other kallikreins, the KLK9 gene was found to be regulated by steroid hormones, mainly estrogens and progestins, in cancer cell lines. Experimental design. We studied the expression of KLK9 by quantitative RT-PCR in 169 breast cancer patients of different stages, grades and histological types. We also compared the relation between KLK9 expression and other clinicopathological variables and patient survival. Results. KLK9 expression is significantly higher in patients with early stage cancers (p = 0.039) and in patients with small tumor size (

KW - Breast cancer

KW - Cancer genes

KW - Cancer predictive markers

KW - Kallikreins

KW - KLK9

KW - Prognostic markers

KW - PSA

KW - Serine proteases

KW - Tumor markers

UR - http://www.scopus.com/inward/record.url?scp=0037359864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037359864&partnerID=8YFLogxK

U2 - 10.1023/A:1022931403825

DO - 10.1023/A:1022931403825

M3 - Article

VL - 78

SP - 149

EP - 158

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -